Biotech Growth Trust (The) (LSE:BIOG) Net Income From Continuing Operations : £74.76 Mil (TTM As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Biotech Growth Trust (The)'s net income from continuing operations for the six months ended in Mar. 2024 was £88.41 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was £74.76 Mil.

Biotech Growth Trust (The) Net Income From Continuing Operations Historical Data

The historical data trend for Biotech Growth Trust (The)'s Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Net Income From Continuing Operations Chart

Biotech Growth Trust (The) Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

61.10

200.56

-202.27

-41.24

74.76

Biotech Growth Trust (The) Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-152.52	37.03	-78.27	-13.65	88.41

Biotech Growth Trust (The) Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £74.76 Mil.

Biotech Growth Trust (The) (LSE:BIOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

BIOGl:UK

Address

25 Southampton Buildings, London, GBR, WC2A 1AL

Website

https://www.biotechgt.com

Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines